News and Insights

The latest news and insights from Genoa Healthcare.

  • Clinical Insights

Panel Discussion: Making Hybrid Service Models Work “Better” By Leveraging Pharmacy Services

Hybrid Healthcare Services The pandemic has dramatically increased the acceptance and use of telehealth and other digital services, while also exacerbating social determinants of health for many Americans. And, while...

  • Nov 11th, 2021
  • Clinical Insights

Thank you to our veterans: Showing our support

Military Veterans Reentering the Civilian Workforce The commitment and leadership that military veterans, including dozens of Genoa team members, bring to our country and communities is a precious gift, and...

  • Nov 11th, 2021
  • Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: New Medication Options in Behavioral Health

Behavioral Health Drug Updates This year the Federal Drug Administration’s Center for Drug Evaluation and Research (CDER) approved a number of new drug therapies to treat behavioral health conditions, including...

  • Oct 8th, 2021
  • Clinical Insights
  • Partnering with Genoa

Webinar: Improving Resident Satisfaction & Outcomes by Integrating Pharmacy Services

Webinar Brief The delivery of consumer services is on the rise in residential, group homes, and assisted living community settings, as consumers shy away from acute care and skilled nursing...

  • Oct 1st, 2021
  • Clinical Insights

Immunizing Medically Underserved Communities: Q&A with Bill Wrigley, Genoa Healthcare’s director of Clinical Product, Immunizations

Increased Risk of Serious Illness in Medically Underserved Communities Providing health care that serves the whole person, including life-saving immunizations, is an important part of protecting the health of people...

  • Jul 30th, 2021
  • Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: What Providers Need to Know: New Medication Options in Behavioral Health

Behavioral Drug Approvals in 2020 The FDA’s Center for Drug Evaluation and Research approved 53 new drugs in 2020 alone, including several novel treatments for schizophrenia and other behavioral health...

  • Jul 6th, 2021
  • Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: Substance Use Disorder and Medication Assisted Therapies

A Rise in Drug Overdoses Deaths from drug overdoses, which have climbed steadily over the past 20 years, rose sharply during the COVID-19 pandemic. This “epidemic within the pandemic” underscored...

  • Jun 30th, 2021
  • Clinical Insights

Webinar: Overcoming Barriers to Medication Adherence Amid COVID-19 and Beyond

Addressing the Challenges of Medication Adherence Amid COVID-19 A recent survey by the Centers for Disease Control and Prevention found that the proportion of U.S. adults with symptoms of anxiety and/or...

  • Apr 28th, 2021
  • Behavioral Health
  • Clinical Insights

Going the distance for consumers with substance use disorder

For Pharmacist Mostafa Saleh, RPh, distance isn’t a barrier in providing great care. Saleh, the site manager at one of Genoa Healthcare’s Portland, Ore., pharmacies, recently had a consumer graduate...

  • Apr 14th, 2021
  • Clinical Insights

Preparing for the COVID-19 Vaccine

Learn How Your Organization Can Prepare for the COVID-19 Vaccine As of mid-December 2020, more than 72 million cases of COVID-19 have been recorded worldwide, leading to over 1.6 million...

  • Dec 22nd, 2020